Transcutaneous pO₂ monitoring in the pediatric intensive care unit
Official title: COMPARISON OF TRANSCUTANEOUS PCO₂ AND PO₂ MEASUREMENTS WITH ARTERIAL BLOOD GAS ANALYSIS IN PEDIATRIC INTENSIVE CARE PATIENTS: IS TRANSCUTANEOUS pO₂ A RELIABLE ALTERNATIVE?
Run by Istanbul Medeniyet University · NCT07478380 · Data updated 2026-11-12
We will test whether noninvasive skin sensors that measure oxygen and carbon dioxide give similar results to arterial blood gases in children in the PICU.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 1 Month to 18 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | Istanbul Medeniyet University Academic / other |
| Locations | 1 site (Istanbul, Kadıkoy) |
| Status | Recruiting |
| Started | March 10, 2026 |
| Main results expected | September 1, 2026 |
| Study ends | October 10, 2026 |
| Registry record updated | March 17, 2026 |
| Trial ID | NCT07478380 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Children aged 1 month to 18 years admitted to the PICU who have an arterial catheter and can tolerate transcutaneous sensor placement while hemodynamically stable are ideal candidates.
✕Probably not a fit
Children with severe skin disease or burns at sensor sites, severe peripheral perfusion impairment or high-dose vasopressor support, or those lacking paired arterial sampling are unlikely to benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational cohort study that collects paired transcutaneous and arterial blood gas measurements from PICU patients who already have arterial lines in place. Paired readings are obtained simultaneously during routine clinical care to minimize timing differences. Agreement between transcutaneous pO₂/pCO₂ and arterial PaO₂/PaCO₂ will be analyzed using correlation and Bland-Altman methods to quantify bias and limits of agreement. The focus is whether transcutaneous pO₂ can reliably substitute for invasive arterial sampling in critically ill children.
Why it matters
Potential benefit: If reliable, transcutaneous monitoring could reduce painful arterial blood draws and provide continuous, noninvasive oxygen and CO2 monitoring for PICU patients.
How similar studies have gone: Prior work in neonates and stable pediatric populations shows mixed accuracy for transcutaneous pO₂/pCO₂ and data in critically ill children are limited and inconsistent.
Who can join: the full rules
Show full inclusion / exclusion criteria
Eligibility Criteria Inclusion Criteria: * Age between 1 month and 18 years * Admission to the Pediatric Intensive Care Unit (PICU) * Presence of an arterial catheter allowing arterial blood gas (ABG) sampling * Simultaneous or paired transcutaneous pCO₂ and pO₂ monitoring available * Hemodynamically stable at the time of measurement Exclusion Criteria: * Severe skin disease, burns, or local skin infection at the transcutaneous sensor site * Severe peripheral perfusion impairment (e.g., refractory shock or high-dose vasopressor support) * Congenital or acquired conditions interfering with accurate transcutaneous measurements * Technical failure or inability to obtain reliable transcutaneous readings * Missing or incomplete paired ABG-transcutaneous measurement data
Where it's running
-
Göztepe Prof. Dr. Süleyman Yalçın City Hospital
Istanbul, Kadıkoy, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Ayşe Aşık, MD
- Email: drayseasik@gmail.com
- Phone: +905533280449
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How well beta-lactam antibiotics reach tissue in critically ill children
This study tests whether three common beta-lactam antibiotics reach sufficient tissue levels in the muscles of critically ill children.
-
Brain blood flow and brain regulation in critically ill kids
This study tests how blood flow in the brain behaves in critically ill children using a noninvasive ultrasound (TCD) to see if brain autoregulation patterns relate to outcomes.
-
BRIDGE: A program to help families make decisions for critically ill kids
This intervention tests whether the BRIDGE program helps parents of seriously ill young children feel more prepared to make decisions and less regret about those choices.
-
Light therapy for children in the pediatric ICU
This project will try daily bedside light therapy for children aged 4–17 in the pediatric ICU to see how easy it is to deliver and whether patients, families, and staff tolerate it.
-
Predicting Extubation Problems With Machine Learning
This study tests whether computer models can predict extubation failure in adults on ventilators in the ICU.
-
Levetiracetam Dosing in Critically Ill on CRRT
This study tests how levetiracetam behaves in the bodies of adults on continuous renal replacement therapy to help figure out the best dosing.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.